Operating Lease, Right-of-Use Asset of Cellectar Biosciences, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cellectar Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Cellectar Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $380,841, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cellectar Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $380,841 -$73,325 -16% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $400,248 -$70,568 -15% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $418,916 -$67,931 -14% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $436,874 -$65,409 -13% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $454,166 -$63,400 -12% 30 Sep 2024 10-Q 18 Nov 2024 2024 Q3
Q2 2024 $470,816 -$61,484 -12% 30 Jun 2024 10-Q 29 Oct 2024 2024 Q2
Q1 2024 $486,847 -$59,658 -11% 31 Mar 2024 10-Q/A 29 Oct 2024 2024 Q1
Q4 2023 $502,283 -$58,051 -10% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $517,566 +$379,469 +275% 30 Sep 2023 10-K/A 29 Oct 2024 2023 FY
Q2 2023 $532,300 +$371,189 +230% 30 Jun 2023 10-K/A 29 Oct 2024 2023 FY
Q1 2023 $546,505 +$363,219 +198% 31 Mar 2023 10-K/A 29 Oct 2024 2023 FY
Q4 2022 $560,334 +$355,690 +174% 31 Dec 2022 10-K/A 29 Oct 2024 2023 FY
Q3 2022 $138,097 -$87,108 -39% 30 Sep 2022 10-K/A 29 Oct 2024 2023 FY
Q2 2022 $161,111 -$83,882 -34% 30 Jun 2022 10-K/A 29 Oct 2024 2023 FY
Q1 2022 $183,286 -$80,756 -31% 31 Mar 2022 10-K/A 29 Oct 2024 2023 FY
Q4 2021 $204,644 -$77,721 -28% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $225,205 -$74,777 -25% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $244,993 -$71,924 -23% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $264,042 -$69,157 -21% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $282,365 -$66,476 -19% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q3 2020 $299,982 -$63,879 -18% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $316,917 -$61,363 -16% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $333,199 -$58,923 -15% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $348,841 +$348,841 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $363,861 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $378,280 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $392,122 31 Mar 2019 10-Q 06 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 09 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.